alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › limitations

limitations

3 studies tagged limitations, dated 2009-09-29 to 2026-06-04. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations 2026-06-04
  2. Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy 2023-04-20
  3. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects 2009-09-29

Studies

3 studies carry this tag.

Date range

2009 to 2026

Top journals

  • Aging and disease 1
  • Experimental gerontology 1
  • Frontiers in neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Optimizing Antibody-Based Therapies for Alzheimer's Disease: From Clinical Limitations to Molecular Engineering Innovations

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Aging and disease 2026-06-04 Treatments

    Antibody-based immunotherapy represents one of the most promising disease-modifying strategies for Alzheimer's disease (AD).

  2. Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in neuroscience 2023-04-20 Treatments

    Neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein are primarily neuropathological features of a number of neurodegenerative diseases, collectively termed tauopathy.

  3. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Experimental gerontology 2009-09-29 Genetics

    An early diagnosis of Alzheimer's disease (AD) and other types of dementia-causing disorders is vital in order to achieve effective treatments.

All topic tags with their study counts